DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Fleming GF, Emens LA, Eder JP. et al.
Clinical activity, safety and biomarker results from a phase Ia study of atezolizumab (atezo) in advanced/recurrent endometrial cancer (rEC).
J Clin Oncol 2017;
35 Suppl: 5585-5585
doi:10.1200/JCO.2017.35.15_suppl.5585
Access:
We do not assume any responsibility for the contents of the web pages of other providers.